Skip to main navigation
Skip to search
Skip to main content
Penn State Home
Help & FAQ
Link opens in a new tab
Search content at Penn State
Home
Researchers
Research output
Research units
Equipment
Grants & Projects
Prizes
Activities
Life after HSCT: Survivorship and long-term issues
Smita Dandekar
Department of Pediatrics
Division of Hematology and Oncology
Penn State Cancer Institute
Cancer Institute, Cancer Control
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
1
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Life after HSCT: Survivorship and long-term issues'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Survivorship
100%
Hematopoietic Stem Cell Transplant
100%
Survivors
50%
Late Effects
20%
Direct Impact
10%
Screening Recommendations
10%
Neurocognitive
10%
Long-term Complications
10%
Expanding Population
10%
Therapeutic Potential
10%
Chronic Conditions
10%
Umbilical Cord Blood
10%
Sickle Cell Disease
10%
Transplant Experiment
10%
β-Thalassemia (β-thal)
10%
Hematological Malignancies
10%
Hematopoietic Stem Cells
10%
Nonmalignant
10%
Supportive Care
10%
Healthcare Management
10%
Treatment-related
10%
Health Strategy
10%
Metabolic Disorders
10%
Alternative Donor
10%
Primary Immunodeficiency
10%
Risky Driving
10%
Risk Exposure
10%
Haploidentical Donor
10%
Stem Cell Source
10%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Beta Thalassemia
100%
Sickle Cell Beta Thalassemia
100%
Hematologic Malignancy
100%
Immune Deficiency
100%
Medicine and Dentistry
Hematopoietic Stem Cell Transplantation
100%
Late Effect
20%
Neoplasm
10%
Supportive Care
10%
Beta Thalassemia
10%
Hematologic Malignancy
10%
Cord Blood
10%
Immune Deficiency
10%
Sickle-Cell Disease
10%
Alternative Donor
10%
Hematopoietic Cell
10%
Metabolic Disorder
10%
Biochemistry, Genetics and Molecular Biology
Hematopoietic Stem Cell Transplantation
100%
Metabolic Disorder
10%
Hematopoietic Cell
10%